Document is current
Any future updates will be listed below
-
Authors
West, Michael D.
Chang, Ching-Fang
Larocca, Dana
Li, Jie
Jiang, Jianjie
Sim, Pamela
Labat, Ivan
Chapman, Karen B.
Wong, Kari E.
Nicoll, James
Van Kanegan, Michael J.
de Grey, Aubrey D. N. J.
Nasonkin, Igor O.
Stahl, Andreas
Sternberg, Hal
-
Funding
Funding for this research was provided by:
BioTime, Inc.
- License Information
-
More Information
Article History
Received: 5 July 2018
Revised: 10 October 2018
Accepted: 21 November 2018
First Online: 8 January 2019
Ethics approval and consent to participate
: Not applicable.
: The authors have given consent for the publication of this manuscript.
: HS, JL, PS, DL, IL, IN, AdG, and MDW are employees and/or stock option or shareholders of AgeX Therapeutics, Inc. (Alameda, CA) and/or BioTime, Inc. (Alameda, CA). IN is an employee and option holder of BioTime, Inc. (Alameda, CA). The other authors declare that they have no competing interests. HyStem® and LifeMap Discovery are technologies owned by or licensed to AgeX Therapeutics for commercial development.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
